All filters
Slidesets
Second generation INSTI regimens for drug naive patients: State of the Art - Daniel Kuritzkes, MD
Presented at:
European HIV Clinical Forum 2019
Slidesets
First line regimens in different European countries 2019 – an overview - Miłosz Parczewski, MD, PhD
Presented at:
European HIV Clinical Forum 2019
Slidesets
When to start antiretroviral therapy after diagnosis – trade-offs and considerations - Anton Pozniak, MD, FRCP
Presented at:
European HIV Clinical Forum 2019
Slidesets
Challenges of Long-Term PrEP - Pep Coll, MD
Presented at:
European HIV Clinical Forum 2019
Slidesets
Update on PrEP use in Europe - Ann Sullivan, MBBS, DIPGUM, DFFP, MD, FRCP
Presented at:
European HIV Clinical Forum 2019
Slidesets
Oral Versus Injectable PrEP - Saye Khoo, MD, PhD
Presented at:
European HIV Clinical Forum 2019
Slidesets
New Treatments and Treatment Paradigms - Sharon Walmsley, FRCPC, MD, MSC
Presented at:
European HIV Clinical Forum 2019
Slidesets
Single-Tablet Regimens Versus Multiple Pills: Is There a Meaningful Difference? - Bonaventura Clotet, MD, PhD
Presented at:
European HIV Clinical Forum 2019
Slidesets
Impact on transmitted and acquired drug resistance - Anne-Geneviève Marcelin, PharmD, PhD
Presented at:
European HIV Clinical Forum 2019
Slidesets
Long-Acting Parenteral Antiretroviral Regimens: Where Might They Fit? - Saye Khoo, MD, PhD
Presented at:
European HIV Clinical Forum 2019
Slidesets
Impact on women’s health & weight gain - Laura Waters, MD
Presented at:
European HIV Clinical Forum 2019
Slidesets
Impact on children and adolescence - Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS
Presented at:
European HIV Clinical Forum 2019